medical
![](https://cdn.abcotvs.com/dip/images/15051093_071124-cc-pfizer-ap-img.jpg?w=660&r=16%3A9)
Pfizer targets obesity with new once-daily Danuglipron drug
Pfizer announced early Thursday morning that it has selected its preferred once-daily modified release formulation of danuglipron, a move that it said was a significant milestone in the obesity drug's development.
More Stories
More Stories